Tag: Hormones: Misc.
Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
Metastasis-directed therapy can delay initiation of systemic therapy in patients with solitary oligorecurrent metastatic lesion
Vaginal Progesterone Not Tied to Reduction in Recurrent Preterm Birth
Results do not appear to be influenced by adherence to vaginal progesterone
Race May Impact Satisfaction With Hormone Therapy for Menopause Symptoms
White women report better quality of life with hormone therapy, while Black women do not
Time-Restricted Eating Has No Impact on Sex Steroids in Women
No change in testosterone, androstenedione, sex-hormone binding globulin among premenopausal or postmenopausal women
Most Teens Continue Gender-Affirming Hormones Into Adulthood
In a recent study, 98 percent continued with hormone treatment at follow-up
Hormonal, Metabolic Parameters of PCOS May Vary by Region
Women with polycystic ovary syndrome who are from Alabama are more likely to be hirsute; those from California are more likely to have hyperandrogenemia
Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer
Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis-free survival
Response to Neoadjuvant Endocrine Therapy for Breast Cancer May Vary by Race
Race is a significant predictor of downstaging in HR+ breast cancer after adjustment for duration of NET, clinical stage
ACOG Develops Consensus on Medical Menstrual Suppression
Guidance emphasizes role of hormonal therapy and should be accompanied by counseling, including discussions of effectiveness of therapy
Impact of Gender-Affirming Hormone Therapy on Kidney Function Examined
Gender-affirming hormone therapy associated with increased serum creatinine in transgender men, but not transgender women
